Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lanreotide for malignant bowel obstruction
NCT00216372Phase 3Completed
- Sponsor
- Ipsen
- Start
- Sep 2003
- Primary completion
- Oct 2008
- Modality
- Peptides
- Countries
- 3
01
Overview
A Phase 3 trial of lanreotide in intestinal obstruction, sponsored by Ipsen. Started Sep 2003; status: completed.
02
Drugs
lanreotide
03
Conditions
intestinal obstruction
Beyond the preview
Go deeper on NCT00216372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216372.